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Abstract
Background
Approximately 75% of children with cleft palate (CP) have Otitis Media with Effusion (OME)
histories. Evidence for the effective management of OME in these children is lacking. The
inconsistency in outcome measurement in previous studies has led to a call for the develop-
ment of a Core Outcome Set (COS). Despite the increase in the number of published COS,
involvement of patients in the COS development process, and methods to integrate the
views of patients and health professionals, to date have been limited.
Methods and Findings
A list of outcomes measured in previous research was identified through reviewing the liter-
ature. Opinion on the importance of each of these outcomes was then sought from key
stakeholders: Ear, Nose and Throat (ENT) surgeons, audiologists, cleft surgeons, speech
and language therapists, specialist cleft nurses, psychologists, parents and children. The
opinion of health professionals was sought in a three round Delphi survey where
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participants were asked to score each outcome using a bespoke online system. Parents
and children were also asked to score outcomes in a survey and provided an in-depth
insight into having OME through semi-structured interviews. The results of the Delphi sur-
vey, interviews and parent/patient survey were brought together in a final consensus meet-
ing with representation from all stakeholders. A final set of eleven outcomes reached the
definition of “consensus in” to form the recommended COS: hearing; chronic otitis media
(COM); OME; receptive language skills; speech development; psycho social development;
acute otitis media (AOM); cholesteatoma; side effects of treatment; listening skills; otalgia.
Conclusions
We have produced a recommendation about the outcomes that should be measured, as a
minimum, in studies of the management of OME in children with CP. The development pro-
cess included input from key stakeholders and used novel methodology to integrate the
opinion of healthcare professionals, parents and children.
Introduction
Cleft lip and palate has an incidence of around 1 in 700 individuals making it one of the most
common congenital malformations worldwide [1]. In children with cleft palate (CP) there is a
tendency towards Eustachian tube dysfunction, which can contribute to the development and
persistence of negative middle ear pressure and the accumulation of mucoid or serous fluid
within the middle ear space (Otitis Media with Effusion (OME), glue ear)[2,3]. The tendency
to develop OME is greater, and persists for longer, in children with CP. Consequently, approxi-
mately 75% of children with CP will have a history of non-trivial OME [1,4].
The consequences of persistent OME can include increased tendency to develop ear infec-
tions (acute otitis media, AOM), long-term middle ear problems (chronic otitis media, COM)
and hearing loss, which can have a negative impact on speech and language development, com-
munication, behavior and educational attainment. There are several approaches to the manage-
ment of OME in children with clefts and they include watchful waiting, the provision of
hearing aids and the insertion of ventilation tubes. However, the evidence underpinning these
strategies is not clear, particularly for children with CP [5].
The MOMENT study (Management of Otitis Media with Effusion in childreN with cleft
palaTe) was a feasibility study designed in response to a commissioned call from the National
Institute of Health Research, Health Technology Assessment Programme to answer the ques-
tion “What is the most appropriate way to manage otitis media with effusion in children with
cleft palate?”. There is currently no Core Outcome Set (COS) for clinical trials of the manage-
ment of OME in children with CP [6]. Therefore, one objective of the study was the develop-
ment of a COS relevant to the treatment of OME in children with CP.
A Core Outcome Set represent the minimum that should be measured and reported in effec-
tiveness trials in a particular condition [7]. The use of a minimum set of core outcomes aims to
increase consistency of reporting in clinical trials. This has been demonstrated for trials in
rheumatological conditions with an increase in the consistency of outcome reporting following
the publication of a COS [8]. A systematic review directed at the early routine insertion of ven-
tilation tubes for the management of OME in children with CP identified a variety of primary
and secondary outcomes together with inconsistency in the method of measurement [9]. The
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use of an agreed set of core outcomes, measured and reported in all randomized controlled tri-
als (RCTs) of treatments for OME in children with CP, could overcome well documented
issues of heterogeneity and outcome reporting bias (ORB) [10–12], whilst at the same time
increasing the potential for meta-analyses of key outcomes in this area.
Specific objectives of the COS development in the MOMENT study were: to identify out-
comes that had been previously reported in studies of the treatment of OME; to prioritise out-
comes from the perspective of health professionals; to prioritise outcomes from the perspective
of patients who can express their views, and parents; and to integrate the opinions of patients,
parents and health professionals into a combined COS.
Limitations of previous methods for COS development
Less than a fifth of previous COS studies have involved public representatives, and the majority
of those included only a handful of patients [11]. Despite evidence that patients may hold dif-
ferent views from health professionals, and a recommendation to include patients in the pro-
cess [9], it is unclear whether different stakeholder group views were transparent to those
involved [11]. This current study implemented a novel design for COS development, including
a new method proposed by children and young people to elicit opinion from children. We
investigated the influence of the method of stakeholder feedback on subsequent opinion. We
report the results from this work here.
Methods
The study protocol for this work, including search strategy and inclusion criteria for the sys-
tematic review, has been previously published [13]. Methods used for the systematic review,
health professional Delphi survey, semi-structured interviews and final study consensus meet-
ing are described briefly below. An online survey of parents and children is described more
fully. An overview of the COS development process is provided in Fig 1.
Systematic Review and generation of the list of outcomes
A list of outcomes previously reported in studies of the treatment of OME was generated by
updating a 2009 systematic review [9] using the same search strategy. The review of papers was
completed by two authors independently (NLH and IAB) and a list of all outcomes measured
in identified papers generated (detailed information is given in the protocol) [13]. This list of
outcomes was further refined to standardize the name given to each of the outcomes. All out-
comes and domains were discussed with members of the Study Advisory Group (SAG) prior to
being finalised. Due to the varied health professional groups likely to be completing the Delphi
an ‘outcome tip’, further describing the outcome, was also written for each outcome and
reviewed by the SAG. The SAG comprised of Speech and Language Therapists (n = 2), Cleft
Surgeons (n = 1), ENT Surgeons (n = 2), Audiologists (n = 2) and Clinical Psychologists
(n = 1). A patient representative was approached during the study and accepted membership
of the SAG but then, due to unforeseen personal circumstances, needed to withdraw from
membership. prior to attending an SAG meeting. The SAG and also the Study Steering Com-
mittee (SSC, comprising a trial methodologist, patient representative, health economist and a
paediatric otorhinolaryngologist) were also given the opportunity to add outcomes to the list
that they considered important.
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Fig 1. Overview of the COS development process.
doi:10.1371/journal.pone.0129514.g001
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Health Professional Delphi Survey
The opinion of health professionals was sought through a three round Delphi survey delivered
using a bespoke online system[13]. Health professionals were eligible to participate in the Del-
phi survey if they were affiliated to a UK Cleft Centre and were a cleft surgeon, ENT surgeon,
audiologist, cleft nurse specialist, clinical psychologist or speech and language therapist. Poten-
tially eligible health professionals were identified through contact with clinical leads at each of
the 15 UK centres who provided a list of current members of their cleft team and their clinical
role (S3 Table).
Prior to completion of round 1 it was agreed that for the feedback of results in round 2 to be
presented by stakeholder groups, approximately 10 participants per stakeholder group would
be required for the presentation of results to be meaningful. In the second round results were
presented by health professional stakeholder group, with an individual seeing only the aggre-
gated results from their particular group together with a reminder of their own round 1 score.
In the third and final round the results of all stakeholder groups, including parents and chil-
dren, presented separately, were shown to each participant together with a reminder of their
round 2 score.
In each round of the Delphi survey, health professionals were asked to score a list of out-
comes using the Grading of Recommendations, Assessment, Development and Evaluations
scale of 1 to 9, with 1 to 3 labelled ‘not important’, 4 to 6 labelled ‘important but not critical’
and 7 to 9 labelled ‘critical’ [14] (S1 Fig). Consensus on outcomes for inclusion in the COS was
determined using a pre-defined definition of consensus (S1 Table).
Opinions of patients and parents
The views of parents of children with a CP aged 0–11 years, and children with a CP aged 6–11
years, were explored in semi-structured interviews conducted by one of the authors (ST), who
does not have a clinical background and was not known to parents or children prior to the
interview. A purposive sample was recruited to provide maximum variation in terms of a
child’s age and gender and type of treatment experienced for OME. Participants were recruited
from two cleft centres in the UK with contrasting approaches to audiology care, one a central-
ized service, the other distributed across a hub and spoke”model. Interviews were audio-
recorded, transcribed verbatim, and then Framework analysis [14] was used to manage and
interpret data. Discussion around outcomes took place throughout interviews. However, there
was a specific section of the topic guide used within interviews that focused on capturing data
on this issue. Results of interviews relating to experiences of OME are reported elsewhere
[15,16].
Semi-structured interviews with parents and children gave in-depth information on out-
comes of importance for these groups. Interviews did not include a discussion of the outcomes
list generated through systematically reviewing the literature because we wanted participants to
express their opinions, in their own words, of what they felt were important results or indica-
tors of successful management of OME. In order to give parents and children the same oppor-
tunity to score outcomes, an online survey, similar to that completed by health professionals,
was developed. This involved review and re-wording, using a plain language description, of
each outcome scored by health care professionals. Each re-worded outcome was tested for
readability using the NIACE SMOG calculator [17]. Understanding was explored with the
Cleft Lip and Palate Association (CLAPA) children and young person’s council (CYPC) and a
local CLAPA ‘Happy Faces’ group. The same outcome wording was used for all participants
with the exception of minor changes such as “your/your child’s” to ensure appropriate context.
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Parents and children aged 7–16 years were asked to consider the appropriate question,
described in Fig 2, and to score each of the outcomes. The labels of the 1–9 scale were modified
for parents whilst children, under the recommendation of the CYPC, scored each outcome
using a traffic light system where the scores 1–3 were represented by a red box labelled as “not
that important”, scores 4–6 as an amber box labelled as “important” and scores 7–9 as a green
box labelled “really important” (S1 Fig). Both parents and children were provided with a free
text box to add anything else that they considered relevant. The definition of consensus (S1
Table) was applied to the results from both parents and children.
Participants of the survey for parents and children were independent of those who com-
pleted a semi-structured interview and were identified using the CLAPA mailing list and social
media pages with a potential reach of 4,710 and 9,564 respectively. An individual email was
sent to all those on the CLAPA mailing list together with a reminder in their e-newsletter. A
link was posted on the Facebook page which included the researcher’s name and photograph
(NLH) and a link to the online survey. There is likely to be substantial overlap with member-
ship of multiple Facebook pages and groups however, it was not possible to assess this.
Final consensus meeting
The consensus meeting brought together all sources of information. The results from the Del-
phi survey of health professionals and the survey of patients and parents were presented along
with the opinions from 43 parents and 37 children who took part in a semi structured inter-
views. An invitation to attend was sent to: health professionals who had completed all rounds
of the online Delphi survey and expressed an interest in attending future meetings; all parents
who had completed an online survey and expressed an interest and provided contact details to
be informed about future meetings; parents who had taken part in a semi-structured interview
whose contact details were still valid; CLAPA members in the North West who subscribed to
the CLAPA mailing list. The format of the consensus meeting comprised a short study over-
view, a summary of results from the semi-structured interviews and a review of each outcome
on the scored list in turn, including presentation of how each stakeholder group had scored the
Fig 2. Initial question asked prior to scoring outcomes for parents, adults and children with cleft palate. The question asked of health professionals is
included for comparison.
doi:10.1371/journal.pone.0129514.g002
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outcome, and the number of stakeholder groups who achieved consensus. Discussion of each
outcome was followed by anonymous electronic scoring by those at the consensus meeting. A
written report of the final meeting was circulated to participants for comment.
Ethics statement
Ethical approval was received from the National Research Ethics Service North West – Greater
Manchester East Research Ethics Committee (Reference 11/NW/0586) for the completion of
semi-structured interviews and invitation of interviewees to the final consensus meeting. Writ-
ten consent was sought for participation in semi-structured interviews, with written proxy con-
sent sought from parents/guardians for their child’s participation. Written assent was also
sought from children aged 6 years and older. Attendance at the consensus meeting was consid-
ered to be implied consent for participation with no written consent provided, this process was
approved by the Research Ethics Committee. Advice was sought from the National Research
Ethics Service who did not consider that ethical approval was required for an online survey of
parental and child opinion. However, full information about initial the study was given in the
initial pages of the online survey and survey completion considered to imply consent.
Results
Systematic review
The search retrieved 85 potentially eligible studies with an additional 42 identified from other
sources, after screening titles and abstracts, all but nine studies were deemed to be irrelevant
(S2 Fig). After further analysis of the full texts one further study was excluded as it was under-
taken to determine the frequency that children with CP pass their new born hearing test [18].
Two non-English papers were identified [19,20], for these the abstract and the review by Pon-
duri et al were used to assess eligibility and extract outcomes. A total of 49 studies were
included: eight studies of children with CP [3,21–27]; seventeen studies [19,20,28–42] identi-
fied in the previous review [9] and 24 studies [43–66] identified from six Cochrane systematic
reviews relating to OME [67–72].
Generation of an outcome list
Each outcome measured was listed by study. Only individual outcomes were included, for
example, where an outcome was measured using different methods this was counted as one
outcome but the methods of measurement noted (S2 Table).
The number of outcomes measured in an individual study varied with a median of 6 out-
comes (range 1–14 outcomes) per paper. Outcomes related to resource use were considered to
be outside the scope of the COS. Consequently, the outcomes, “necessity to visit doctor” and
“level of speech therapy support required” were not considered in the list of outcomes. The
final list of outcomes used in round 1 of the Health Professionals Delphi comprised 45 individ-
ual outcomes (43 identified from the systematic review and two added by the Study Steering
Committee) grouped under 14 domains (Table 1). The list of outcomes scored by parents and
children included the combination of some outcomes, for example those that related to specific
clinical observations, so that a total of 36 outcomes were scored (Table 1).
Identification of outcomes of importance to parents and children with CP
Semi-structured interviews were completed with 43 parents of 37 children, and 22 children,
according to the sampling matrix described in the trial protocol [13]. Interviews with parents
lasted, on average, 40 minutes, whilst those with children took, on average, 20 minutes. Parent
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Table 1. Outcomes scored by health professionals, parents and children.
Original Outcome Outcome Domain 7-10yrs 11–16 yrs Parents
Internalising Behaviour Things about behaviour/
Things about your child's
behaviour/Things about
behaviour
How lonely you feel, feeling
like an outsider
How lonely you feel, feeling
like an outsider
How lonely your child feels,
feeling like an outsider
Externalising Behaviour Things about behaviour/
Things about your child's
behaviour/Things about
behaviour
How angry you are towards
others
How angry you are towards
others
How angry your child is
towards others
Atelectasis, persistent
tympanic membrane
retraction, tympanosclerosis
Things about having
problems with your ears for
a long time/ Things about
your child having problems
with their ears for a long
time
Not having problems inside
your ear caused by having
lots of ear infections over a
long time (more than 3
months)
Not having problems inside
your ear caused by having
lots of ear infections over a
long time (more than 3
months)
Your child not having
problems inside their ear
caused by having lots of
ear infections over a long
time (more than 3 months)
Cholesteatoma Things about having
problems with your ears for
a long time/ Things about
your child having problems
with their ears for a long
time
Not having problems inside
your ear caused by bad skin
growing behind your ear
drum.
Not having problems inside
your ear caused by bad skin
growing behind your ear
drum.
Your child not having
problems inside their ear
caused by bad skin
growing behind your ear
drum.
Chronic Otitis Media Things about having
problems with your ears for
a long time/ Things about
your child having problems
with their ears for a long
time
Not having problems inside
your ear caused by having
glue ear for a long time
(more than 3 months)
Not having problems inside
your ear caused by having
glue ear for a long time
(more than 3 months)
Your child not having
problems inside their ear
caused by having glue ear
for a long time (more than
3 months)
Persistent tympanic
membrane perforation
Things about having
problems with your ears for
a long time/ Things about
your child having problems
with their ears for a long
time
Not having problems inside
your ear caused by having a
hole in your ear drum for a
long time (more than 3
months
Not having problems inside
your ear caused by having a
hole in your ear drum for a
long time (more than 3
months
Your child not having
problems inside their ear
caused by having a hole in
your ear drum for a long
time (more than 3 months
Academic achievement,
cognitive development,
developmental progress,
intelligence, literacy,
phonological memory
Things about school and
making friends
How well you are doing at
school
How well you are doing at
school or college
How well your child is
doing at school or college
Psycho social development Things about school and
making friends
How well you are learning to
make friends and speak to
new people
How well you are learning to
make friends and speak to
new people
How well your child is
learning make friends and
speak to new people
Hearing Things about how your ear
feels and works/Things
about how your child's ear
feels and works
How well you can hear How well you can hear How well your child can
hear
Otalgia Things about how your ear
feels and works/Things
about how your child's ear
feels and works
How painful your ear is How painful your ear is How painful your child's ear
is
Otorrhoea Things about how your ear
feels and works/Things
about how your child's ear
feels and works
Not having infected liquid
leaking out of your ear
Not having pus (infected
liquid) leaking out of your ear
Your child not having pus
(infected liquid) leaking out
of their ear
Tinnitus Things about how your ear
feels and works/Things
about how your child's ear
feels and works
How much you hear buzzing
or ringing noises
How much you hear buzzing
or ringing noises
How much your child hears
buzzing or ringing noises
(Continued)
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Table 1. (Continued)
Original Outcome Outcome Domain 7-10yrs 11–16 yrs Parents
Vertigo Things about how your ear
feels and works/Things
about how your child's ear
feels and works
How dizzy you feel How dizzy you feel How dizzy your child feels
Eustachian tube function Things about how the
middle part of your ear
works/Things about how
the middle part of your
child's ear works
How well a special tube in
your ear works. If this tube
doesn’t work properly you
might hear popping and
crackling noises.
How well a special tube in
your ear works. If this tube
doesn’t work properly you
might hear popping and
crackling noises.
How well a special tube in
your child's ear works. If
this tube doesn't work
properly your might hear
popping and crackling
noises.
Stapedial reflex Things about how the
middle part of your ear
works/Things about how
the middle part of your
child's ear works
How well your ear works
when it hears a loud noise
How well your ear works
when it hears a loud noise
How well your child's ear
works when it hears a loud
noise
Nasal obstruction Things about how your
nose feels/Things about
how your child's nose feels
How well you can breathe
through your nose
How well you can breathe
through your nose
How well your child can
breathe through their nose
Rhinitis Things about how your
nose feels/Things about
how your child's nose feels
How much your nose feels
runny or stuffy
How much your nose feels
runny or stuffy
How much your child's
nose feels runny or stuffy
Acute otitis media (AOM) Things about glue ear and
ear infections
Not having ear infections Not having ear infections Your child not having ear
infections
Otitis media with effusion
(OME)
Things about glue ear and
ear infections
Not having glue ear and
being able to hear better
Not having glue ear and
being able to hear better
Your child not having glue
ear
Temporary tympanic
membrane perforation
Things about glue ear and
ear infections
Not having a hole in your
eardrum that only lasts for a
few weeks
Not having a hole in your
eardrum that lasts for a few
weeks
Your child not having a
hole in their eardrum that
lasts for a few weeks
Consonant production,
consonant production—cleft
related speech patterns,
expressive language skills
Things about talking Being able to say all your
words clearly and grownups
and children understanding
what you say
Being able to say all your
words clearly and grownups
and children understanding
what you say
Your child being able to
say all their words clearly
so that adults and other
children can understand
what they said
Parent's perspective of
speech
Things about talking How much you talk like
someone without a cleft
palate
How much you talk like
someone without a cleft
palate
How much your child talks
like someone without a
cleft palate
Receptive language skills Things about talking Being able to listen and
understand what other
people say
Being able to listen and
understand what other
people say
Your child being able to
listen and understand what
other people say
Speech development Things about talking How well your parents think
you are speaking
How well your parents think
you are speaking
How well you think your
child is speaking
Speech intelligibility Things about talking Speaking as well as other
children the same age as
you
Speaking as well as other
children the same age as
you
Your child speaking as well
as other children who are
the same age
Speech signs of
velopharyngeal insufficiency
Things about talking Your speech not sounding
different to other children
Your speech not sounding
different to other children
Your child's speech not
sounding different to other
children
Early extrusion or blockage of
ventilation tubes
Things about grommets How often your grommets/
ventilation tubes fall out or
don't work
How often your grommets/
ventilation tubes fall out or
don't work
How often your child's
grommets/ventilation tubes
fall out or don't work
Necessity to remove
ventilation tubes
Things about grommets Not needing another
operation to take grommets/
ventilation tubes out
Not needing another
operation to take grommets/
ventilation tubes out
Your child not needing
another operation to take
grommets/ventilation tubes
out
Original Outcome Outcome Domain 7–16
year old and adults/parents
Outcome 7-10yrs Outcome 11–16 yrs Outcome Parents
(Continued)
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and child responses to specific questions about outcomes were cross checked against the out-
comes list generated from the systematic review of the literature and, as the semi-structured
interviews were in parallel to the first round of the health professionals Delphi, were also
checked against any free text responses provided by health professionals in round 1. Two inves-
tigators (IAB and NLH) mapped each outcome from the interviews against the list of outcomes
after round 1. No new outcomes were identified.
Online survey of parents and children
Two hundred and ninety three people accessed the online survey and 253 answered the initial
question regarding eligibility. Of the 235 eligible only 51 (22%) completed the survey.
Responses were received from 35 parents, eight adults and eight children. Of the eight children,
four were in the 7–10 years age group and four aged 11–16 years.
The results were reviewed against the definition of consensus agreed prior to the start of the
study [13]. Using this definition, parents and children had reached “consensus in” for 35 and
11 outcomes respectively (Table 2).
Table 1. (Continued)
Original Outcome Outcome Domain 7-10yrs 11–16 yrs Parents
Requirement for repeated
ventilation tubes
Things about grommets Not needing another
operation to have new
grommets/ventilation tubes
because the old ones fell
out.
Not needing another
operation to have new
grommets/ventilation tubes
because the old ones fell
out.
Your child not needing
another operation to have
new grommets/ventilation
tubes because the old
ones fell out.
Child stress Things about how you or
your parents feel/ Things
about how you or your
child feels
How often you feel upset or
angry
How often you feel upset or
angry
How often your child feels
tense or upset
Parental stress Things about how you or
your parents feel/ Things
about how you or your
child feels
How often your parents feel
upset or angry
How often your parents feel
upset or angry
How often you feel tense or
upset
Parental satisfaction with
treatment
Things about how well
your child's treatment has
worked
How well your parents think
that hearing aids or
grommets have improved
your hearing
How well your parents think
that hearing aids or
grommets have improved
your hearing
How well you think that
hearing aids or grommets
have improved your child's
hearing
Side effects of Treatment Things about problems
caused by treatment/
Things about problems
caused by your child's
treatment
Not having problems, that
can sometimes happen, that
are caused by a treatment
you have for glue ear
Not having problems, that
can sometimes happen, that
are caused by a treatment
you have for glue ear
Your child not having
problems, that can
sometimes happen, that
are caused by a treatment
they have for glue ear
Upper Respiratory Tract
Infection
Things about infections in
the ear, nose or mouth
Not having infections in your
ear, nose or mouth
Not having infections in your
ear, nose or mouth
Your child not having
infections in their ear, nose
or throat
Child's satisfaction with
treatment
Other things How much you think
treatment has made you
better
How much you think
treatment has made you
better
How much your child thinks
that treatment has made
them better
Child's perspective of speech Other things How normal you think you
sound when you are talking
How normal you think you
sound when you are talking
How normal your child
thinks they sound when
they are talking
Psychological wellbeing Not scored Not scored Not scored Not scored
Listening skills Not scored Not scored Not scored Not scored
Psychosocial wellbeing Not scored Not scored Not scored Not scored
Hyperacusis Not scored Not scored Not scored Not scored
doi:10.1371/journal.pone.0129514.t001
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Table 2. Summary of all groups reaching consensus for individual outcomes scored in the health professional Delphi survey and online survey
for parents and children.
Outcome Round 3 and survey of parents and children with CP
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Internalising Behaviour * *
Externalising Behaviour * *
Atelectasis * * * * *
Cholesteatoma * * * * *
Chronic Otitis Media * * * * * * *
Persistent tympanic membrane perforation * * *
Persistent tympanic membrane retraction * * * *
Tympanosclerosis * * *
Academic achievement * *
Cognitive development * * * *
Developmental progress * * * *
Intelligence *
Literacy * *
Phonological memory * *
Psycho social development * * * * *
Hearing * * * * * * * *
Otalgia * * *
Otorrhoea * * *
Tinnitus * *
Vertigo * *
Eustachian tube function * * *
Stapedial reflex * *
Nasal obstruction
Rhinitis
Acute otitis media (AOM) * * * * *
Otitis media with effusion (OME) * * * * * * *
Temporary tympanic membrane perforation *
Consonant production * * * * *
Consonant production—cleft related speech patterns * * * *
Expressive language skills * * *
Parent's perspective of speech * *
Receptive language skills * * * * * *
Speech development * * * * * *
Speech intelligibility * * * * *
Speech signs of velopharyngeal insufficiency * * *
(Continued)
Stakeholder Views in COS Development for OME
PLOSONE | DOI:10.1371/journal.pone.0129514 June 26, 2015 11 / 22
Identification of Outcomes of Importance to Health Professionals
Round 1 –Health Professionals. The overall response rate per round is given in S4 Table.
The number of outcomes reaching consensus within each stakeholder group in each round is
shown in Table 3.
Table 2. (Continued)
Outcome Round 3 and survey of parents and children with CP
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Early extrusion or blockage of ventilation tubes * * *
Necessity to remove ventilation tubes * * * * *
Requirement for repeated ventilation tubes * * * * *
Child stress * * *
Parental stress * *
Parental satisfaction with treatment * * * * *
Side effects of treatment * * * *
Upper respiratory tract infection *
Child's satisfaction with treatment * * * * *
Child's perspective of speech * * * * *
Psychological wellbeing† * * * / /
Listening skills† * * * * / /
Psychosocial wellbeing† * * * * / /
Hyperacusis† / /
† Not scored by parents or children
doi:10.1371/journal.pone.0129514.t002
Table 3. Number of outcomes achieving consensus.
Number of outcomes reaching consensus
in round 1 and staying in consensus
throughout
Additional outcomes achieving
consensus in round 2 compared to
round 1
Additional outcomes achieving
consensus in round 3 compared to
round 2
Cleft Surgeon 14 10 0†
ENT Surgeon 4 0 3
Specialist Cleft
Nurse
32 3 4
Speech and
Language Therapist
13 10 0*
Psychologist 7 4 1
Audiologist 6 13 0
† six fewer outcomes achieved consensus in round 3 compared to round 2
* one less outcome achieved consensus in round 3 compared to round 2.
doi:10.1371/journal.pone.0129514.t003
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The 18 free text responses provided by health professionals in round 1 were reviewed by the
SMG and SAG. Eight responses represented a comment and two relating to the use of hearing
aids were considered outside the scope of the study. The remaining eight described potential
outcomes of which two (listening skills and psychosocial wellbeing) were not already repre-
sented and therefore were taken forward to round 2. Thus in round two health professionals
scored 47 outcomes.
Round 2 –Health Professionals. Of the 104 participants who completed round 1 only 99
were eligible to participate in round 2: three clinical geneticists were excluded from further
rounds as they were not involved in the management of OME and two participants were on
maternity leave at the time of round 2 and therefore would not be able to participate further. A
total of 85 responses were received in round 2 (86% of those completing round 1 and eligible
for round 2). Participants were shown their own score from round 1 alongside the percentage
of participants giving each score from their own stakeholder group. They were informed that
they could change their score or keep it the same as their score in round 1. The median percent-
age of scores changed between round 1 and 2 was 18% (range 0–100%). One participant
changed 100% of their score in round 1 whilst six participants (7%) made no changes to their
scores.
Round 3- Health Professionals. After round 2, four participants left the cleft service and
so were no longer eligible to participate in round 3. A total of 73 responses were received (90%
of those completing round 2 and eligible to complete round 3). All sites were represented in the
responses to round 3 with a variable representation of sites and health professional stakeholder
groups within site (S4 Table). In round 3, 49 outcomes were scored. One additional outcome
“hyperacusis” (sensitivity to loud noises) was identified from free text responses to the parent/
child survey. A typing error in the entry of outcomes onto the online system in round 2 had led
to “psychosocial wellbeing” being listed as “psychological wellbeing” which is considered to be
a different outcome. Therefore in round 3 this was clarified and participants asked to score
“psychosocial wellbeing” as well as re-score “psychological wellbeing”. This time, participants
were shown their own score in round 2, together with the scores for each of the stakeholder
groups including parents and children. The median percentage of scores changed between
round 2 and 3 was 21% (range 0–83%). Six participants (8%) made no changes to their scores
and no participants changed all scores.
Consensus Matrix. The scores in round 3 were compared against the definition of consen-
sus to determine which stakeholder groups had reached the definition of “consensus in”. After
round 3 all eight stakeholder groups (health professionals plus parents and children) had
reached “consensus in” for one outcome “hearing”. Results for all outcomes are given in
Table 3.
Attrition bias between rounds. To identify whether attrition in round 2 would introduce
bias, the average score across outcomes from round 1 was calculated for each participant and
then compared for those completing both rounds (n = 85) versus those completing round 1
only (n = 14). Likewise in round 3, scores were compared for those completing both rounds 2
and 3 (n = 73) versus those completing round 2 only (n = 8). The results of those who did not
complete round 2 or round 3 did not represent extreme views suggesting that bias had not
been introduced through attrition between rounds (S3 and S4 Figs).
Variability in outcomes achieving consensus between rounds. Consensus was reached
on additional outcomes within all health professional groups when shown results from either
their own stakeholder group, or all groups plus those from parents and children with CP, or
both (Table 3). This suggests the Delphi, as opposed to a one-off survey, was a useful exercise.
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Consensus Meeting
Twenty five participants attended the consensus meeting of whom 14 were eligible to vote. All
stakeholder groups with the exception of clinical psychologists were represented (S6 Table).
Outcomes were discussed in the order of the number of stakeholder groups achieving con-
sensus. Each outcome was categorized based on the following: 1 Discussed and voted (19 out-
comes); 2 Discussed and agreed to combine with another outcome and to be considered as part
of the “how” an outcome is measured (14 outcomes); 3 Discussed and agreed that further dis-
cussion with parents was needed (seven outcomes); 4 Agreed not to discuss further or vote—
not in the COS (nine outcomes). A full breakdown of outcomes discussed at the consensus
meeting is provided in S5 Table.
The evidence from the health professional Delphi, the parent and child survey and discus-
sion at the consensus meeting followed by voting, were integrated and a COS proposed. This
was then further discussed and approved at a follow up meeting of the SAG.
The consensus meeting followed by discussion with the SAG identified 11 outcomes that
required further discussion with parents. For example, at the consensus meeting the outcome
“listening skills” reached consensus for inclusion in the COS. This outcome was added by health
care professionals as part of their Delphi and was not scored by parents or children. Conse-
quently “listening skills” was considered to require further discussion with parents. Outcomes
identified at the consensus meeting as requiring additional input, were discussed with parents at
a follow up meeting held as a parallel workshop at the CLAPA annual conference, October 2014.
Nine parents and one cleft surgeon took part in the workshop. The session included discussion
and, if needed, further explanation of each outcome. Each outcome was scored anonymously
using an electronic scoring system for immediate feedback. The scores from the workshop were
combined with the scores from the consensus meeting and the definition of consensus applied.
Following voting, “listening skills” was confirmed for inclusion in the COS. Two additional out-
comes, “cholesteatoma” and “otalgia”, also reached consensus in. All outcomes meeting the defi-
nition of consensus and included in the recommended COS are shown in Table 4.
Discussion
This work has produced a consensus recommendation about what outcomes should be mea-
sured in studies related to the management of OME in children with CP and was undertaken
Table 4. Recommended core outcome set.
Outcome Number of stakeholder groups scoring as
“consensus IN”
Percentage scoring 7–9 at
meeting
Percentage scoring 1–3 at
meeting
Hearing 8 100% 0%
Chronic Otitis Media 7 100% 0%
Otitis media with effusion
(OME)
7 93% 7%
Receptive language skills 6 100% 0%
Speech development 6 93% 7%
Psycho social development 5 71% 7%
Acute otitis media (AOM) 5 78% 7%
Cholesteatoma 5 71% † 0%†
Side effects of treatment 4 100% 0%
Listening skills 4 91%† 0%†
Otalgia 3 82%† 14%†
† - includes scores from follow up meeting with parents
doi:10.1371/journal.pone.0129514.t004
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as a component of the MOMENT study which investigated the feasibility of conducting an
RCT in this area (Health Technology Assessment reference 09/167/02). The recommended
COS includes: the presence of specific otological conditions (COM, OME and AOM); the
potential physical or functional sequelae of these specific otological conditions (hearing loss,
cholesteatoma, listening skills, psychosocial development, hearing, receptive language skills
and speech development); and the potential negative consequences of treatment (side effects of
treatment). The outcome “side effects of treatment” included in the COS will be dependent on
the interventions/treatments that are being compared in a particular study
A recent systematic review of studies describing COS development demonstrated variability in
stakeholder involvement with only 18% of studies including public representatives in the process
[6]. The opinions of parents and children about the treatment of OME for children with CP are
essential because this group will experience both the benefits and adverse effects of treatments,
and be involved in decision-making about treatment. Importantly, the development of the COS in
theMOMENT study has considered the opinion of patients and parents to ensure that outcomes
regarded as most important, and included in the COS, are relevant to this stakeholder group.
We have demonstrated that clinical outcomes can be translated into plain language and that
both parents and children are able to score these outcomes in an online survey. In this particu-
lar study, children were more discerning than their parents when considering which outcomes
are most important to them with 11 outcomes reaching the definition of “consensus in”.
The use of an online survey of parents and children has allowed a broader range of out-
comes to be considered than if interviews alone were used. Time constraints of the present
study meant that only a one off survey was possible. However, future COS development should
consider multiple rounds completed by patients/parents stakeholders in which the responses
from health professionals can also be taken into account. Certainly the multiple rounds com-
pleted by health professionals resulted in changes being made to scores indicating that the
responses of peers, parents and children and other health professional groups had an impact
on the perceived importance of outcomes.
Strengths and limitations
We have used an efficient online system to deliver a multiple round Delphi to health care pro-
fessionals that allowed automated collating of scores and feedback in each round together with
automated email alerts to promote completion. We have shown that individuals do reflect on,
and are influenced by, other groups' opinions about the importance of outcomes. This online
system was also successfully modified for use by parents and children in a one off survey.
Both clinical and patient stakeholders were engaged, with the response rate of health profes-
sionals similar to that reported in other Delphi surveys [73–75]. Notably the attrition rate was
low with those taking part in round 1 likely to complete all rounds; as a result, no attrition bias
was introduced. Whilst clinical stakeholder representation was good the number of parents
and children completing the online survey and attending the face to face consensus meeting
was lower than expected. In the present study it was not possible to ascertain whether the
length of the survey for parents and children, the method of delivery or indeed the importance
of the research question, due to perceived impact of OME, contributed to the low response
rate. It is possible that those individuals completing the online survey are not representative of
the wider group in terms of their views about important outcomes. Thirty seven parents were
interviewed and these considered fewer outcomes to be critically important compared to
parents who completed the online survey. However, with the exception of “externalising behav-
iour”, mentioned by one parent but not as the most important outcome, the opinions of those
parents who were interviewed were comparable with the opinions expressed by parents
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completing the online survey. Research is needed on how best to engage with patients and/or
their parents to facilitate patient involvement with the different stages of the COS
development.
Future Work
The consensus meeting and follow up meeting with parents has resulted in a COS which rec-
ommends what to measure. However, if future research measures these outcomes in different
ways it will still be difficult to compare studies. The next steps will involve consideration of
how each of these outcomes should be defined and measured. For each outcome, definitions
and measurement instruments will need to be reviewed, whether a validated tool already exists
and what methods have been used to measure this outcome in previous studies, as described in
the systematic review (S2 Table).
For each of the outcomes included in the recommended COS this will include: consideration
of methods of assessing hearing that might be influenced by the intervention, for example, dif-
fering methods depending on ventilation tube or hearing aid use; agreeing a definition of COM
and methods of measurement; determining which aspects of speech development should be
measured and identifying whether methods of measurement are already available; reviewing
methods for assessment of receptive language, psychosocial development, AOM, listening
skills, cholesteatoma and otalgia; establishing the most appropriate way to measure side effects
of treatment; consideration of the impact of patient age group on the chosen method of assess-
ment. With the exception of “listening skills” all outcomes have been measured in one or more
of the studies identified in the systematic review.
Guidelines for the selection of outcome measurement instruments to be included in a COS
are being developed by the Core Outcome Measurement Instrument Selection (COMIS) proj-
ect [76] and will be consulted when available. Furthermore, the UK Cleft Audit means that for
some outcomes there are potentially methods of measurement that have already been agreed
by health professionals providing cleft care in the UK [77,78].
Our study recommends a core outcome set but also acknowledges that further work is
needed to identify agreed methods of measurement for each of the outcomes as this is beyond
the scope of the current study. As part of the methods development process consideration will
be given to the age at which outcome assessments are appropriate and this will inform the
length of follow up needed in a given trial.
The length of follow up will not be mandated and a similar approach will be adopted as by the
OMERACT group where, if appropriate, outcomes will only be considered core should they be
appropriate to the age group of participants and duration of follow up. For example, the OMER-
ACT core outcome set includes one outcome which is only relevant should the duration of follow
up be greater than 52 weeks[79]. The MOMENT study has involved multiple key stakeholder
groups from the UK to ensure that a COS is suitable and well accepted in future research. How-
ever, to promote good uptake of the COS into future studies international consensus is needed.
Cleft organisations exist in both Europe (The European Cleft Organisation) and the United States
(American Cleft Palate-Craniofacial Association) and we plan to work with COMET [80]to pur-
sue engagement of international health professionals through their membership.
It should also be noted that a COS is not static and should be revised or updated as new infor-
mation becomes available. Should future trials using the COS recommended in this paper iden-
tify difficulties in its application then review of the included outcomes would be warranted.
Whilst OME affects around 75% of children with CP, it is also a common condition for chil-
dren without cleft, with almost a fifth of children aged 1–5 years affected [1]. The COS
described in the current study includes outcomes that have been identified from previous
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studies in both cleft and non-cleft populations suggesting that they may also be of relevance to
studies of OME in children without CP. Further work in this area and engagement with stake-
holders is warranted.
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